• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国北京地区大流行性流感 A(H1N1 2009)血清学调查。

Serologic survey of pandemic influenza A (H1N1 2009) in Beijing, China.

机构信息

Beijing Center for Disease Prevention and Control, Capital Medical University, School of Public Health and Family Medicine, Beijing, PR China.

出版信息

Prev Med. 2011 Jan;52(1):71-4. doi: 10.1016/j.ypmed.2010.10.006. Epub 2010 Nov 1.

DOI:10.1016/j.ypmed.2010.10.006
PMID:21047527
Abstract

OBJECTIVE

To examine the frequency and distribution of antibodies against pandemic influenza A (H1N1 2009) [H1N1] in populations in Beijing and elucidate influencing factors.

METHODS

In January 2010, a randomized serologic survey of pandemic influenza A (H1N1 2009) was carried out. Six districts that were randomly selected with a total of 4601 participants involved in the survey have their antibody level tested by hemagglutination inhibition assay.

RESULTS

Among the 4601 participants, the overall seropositive rate for pandemic influenza A (H1N1 2009) antibodies was 31.7%. The seropositivity prevalence in participants who received the pandemic H1N1 vaccination was 60.9%. Only 53.1% of the pandemic influenza A (H1N1 2009) seropositive individuals who had not received the vaccination experienced respiratory tract infection symptoms. Multivariate logistic regression revealed that factors such as age, occupation, dwelling type, whether the participant's family included students in school, and the vaccination history with pandemic influenza A (H1N1 2009) were associated with antibody titers (p<0.05).

CONCLUSIONS

Our data indicated that almost 30.0% of the residents had appropriate antibody titers against pandemic influenza A (H1N1 2009) in Beijing, and these titers may provide an immune barrier.

摘要

目的

调查北京地区人群中针对甲型 H1N1 流感(H1N1)的抗体频率和分布,并阐明其影响因素。

方法

2010 年 1 月,采用随机血清学调查方法对甲型 H1N1 流感进行了调查。随机选择了 6 个区,共 4601 名参与者接受了血凝抑制试验检测抗体水平。

结果

在 4601 名参与者中,甲型 H1N1 流感抗体的总血清阳性率为 31.7%。接种甲型 H1N1 流感疫苗的参与者的血清阳性率为 60.9%。未接种疫苗的甲型 H1N1 流感抗体阳性者中仅有 53.1%出现呼吸道感染症状。多因素 logistic 回归显示,年龄、职业、居住类型、参与者家庭中是否有在校学生以及甲型 H1N1 流感疫苗接种史等因素与抗体滴度有关(p<0.05)。

结论

本研究数据表明,北京市近 30.0%的居民对甲型 H1N1 流感具有适当的抗体滴度,这些滴度可能提供了免疫屏障。

相似文献

1
Serologic survey of pandemic influenza A (H1N1 2009) in Beijing, China.中国北京地区大流行性流感 A(H1N1 2009)血清学调查。
Prev Med. 2011 Jan;52(1):71-4. doi: 10.1016/j.ypmed.2010.10.006. Epub 2010 Nov 1.
2
Serological survey of 2009 H1N1 influenza in residents of Beijing, China.中国北京居民中 2009 年 H1N1 流感的血清学调查。
Epidemiol Infect. 2011 Jan;139(1):52-8. doi: 10.1017/S0950268810002189. Epub 2010 Sep 21.
3
Mixed infections of pandemic H1N1 and seasonal H3N2 viruses in 1 outbreak.1 起暴发疫情中季节性 H3N2 与大流行 H1N1 流感病毒的混合感染。
Clin Infect Dis. 2010 May 15;50(10):1359-65. doi: 10.1086/652143.
4
Influenza surveillance in Shenzhen, the largest migratory metropolitan city of China, 2006-2009.2006-2009 年中国最大的移民城市深圳流感监测。
Epidemiol Infect. 2011 Oct;139(10):1551-9. doi: 10.1017/S0950268810002694. Epub 2010 Dec 7.
5
Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.中国北京医护人员对甲型 H1N1 流感病毒疫苗的接受情况。
Vaccine. 2011 Feb 11;29(8):1605-10. doi: 10.1016/j.vaccine.2010.12.077. Epub 2011 Jan 4.
6
Epidemiological investigation of an outbreak of pandemic influenza A (H1N1) 2009 in a boarding school: serological analysis of 1570 cases.一起寄宿制学校甲型 H1N1 流感大流行疫情的流行病学调查:1570 例血清学分析。
J Clin Virol. 2011 Mar;50(3):235-9. doi: 10.1016/j.jcv.2010.11.012. Epub 2010 Dec 30.
7
2009 pandemic characteristics and controlling experiences of influenza H1N1 virus 1 year after the inception in Hangzhou, China.中国杭州 2009 年流感大流行特征及甲型 H1N1 流感病毒控制经验 1 年后评估
J Med Virol. 2010 Dec;82(12):1985-95. doi: 10.1002/jmv.21964.
8
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.中国 2009 年甲型 H1N1 流感大流行病毒感染初始病例的临床特征。
N Engl J Med. 2009 Dec 24;361(26):2507-17. doi: 10.1056/NEJMoa0906612. Epub 2009 Dec 9.
9
Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.香港人群对甲型 H1N1 流感病毒的血清学免疫和血清学反应。
J Med Virol. 2010 Nov;82(11):1809-15. doi: 10.1002/jmv.21895.
10
A review of the dynamics and severity of the pandemic A(H1N1) influenza virus on Réunion island, 2009.2009 年留尼汪岛甲型 H1N1 流感大流行病毒动力学和严重程度的回顾。
Clin Microbiol Infect. 2010 Apr;16(4):309-16. doi: 10.1111/j.1469-0691.2010.03171.x. Epub 2010 Jan 28.

引用本文的文献

1
Assessment of Baseline Antibodies to Pandemic Influenza A/H1N1/2009 Virus in Ogbomoso, Oyo State, Nigeria.尼日利亚奥约州奥戈莫索市2009年甲型H1N1大流行性流感病毒基线抗体评估
Pathog Glob Health. 2018 Jun;112(4):227-231. doi: 10.1080/20477724.2018.1460944. Epub 2018 Apr 23.
2
Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.与法国普通人群季节性后血清学滴度及大流行性 A/H1N1 病毒感染风险因素相关的因素。
PLoS One. 2013 Apr 16;8(4):e60127. doi: 10.1371/journal.pone.0060127. Print 2013.
3
Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.
中国北京 2010/2011 年流行季节中 2009 年甲型 H1N1 流感血清流行率和 2010/2011 年流感疫苗的效果。
Influenza Other Respir Viruses. 2012 Nov;6(6):381-8. doi: 10.1111/j.1750-2659.2011.00326.x. Epub 2011 Dec 30.
4
Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009.2009 年甲型 H1N1 流感病毒抗体的流行情况,佛罗里达州坦帕湾——2009 年 11 月至 12 月。
PLoS One. 2011;6(12):e29301. doi: 10.1371/journal.pone.0029301. Epub 2011 Dec 20.
5
Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009-May 2010.2009 年 1 月至 2010 年 5 月安大略省大流行性流感 H1N1 的血清流行率。
PLoS One. 2011;6(11):e26427. doi: 10.1371/journal.pone.0026427. Epub 2011 Nov 14.
6
High incidence of severe influenza among individuals over 50 years of age.50岁以上人群中严重流感的高发病率。
Clin Vaccine Immunol. 2011 Nov;18(11):1918-24. doi: 10.1128/CVI.05357-11. Epub 2011 Sep 7.
7
The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination.在接种疫苗之前,各国与大流行性流感 H1N1 2009 相关的感染的特定年龄人群累积发病率相似。
PLoS One. 2011;6(8):e21828. doi: 10.1371/journal.pone.0021828. Epub 2011 Aug 5.